Pathstone Holdings LLC Acquires 632 Shares of Balchem Co. (NASDAQ:BCPC)

Pathstone Holdings LLC lifted its holdings in shares of Balchem Co. (NASDAQ:BCPC) by 6.5% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 10,361 shares of the basic materials company’s stock after purchasing an additional 632 shares during the period. Pathstone Holdings LLC’s holdings in Balchem were worth $1,824,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Envestnet Portfolio Solutions Inc. boosted its holdings in Balchem by 1.5% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 3,926 shares of the basic materials company’s stock valued at $604,000 after acquiring an additional 59 shares during the last quarter. Inspire Investing LLC boosted its holdings in Balchem by 2.7% in the third quarter. Inspire Investing LLC now owns 2,348 shares of the basic materials company’s stock valued at $413,000 after acquiring an additional 62 shares during the last quarter. Hsbc Holdings PLC boosted its holdings in Balchem by 1.5% in the second quarter. Hsbc Holdings PLC now owns 4,915 shares of the basic materials company’s stock valued at $757,000 after acquiring an additional 75 shares during the last quarter. Atomi Financial Group Inc. boosted its holdings in Balchem by 6.1% in the third quarter. Atomi Financial Group Inc. now owns 1,674 shares of the basic materials company’s stock valued at $295,000 after acquiring an additional 96 shares during the last quarter. Finally, Xponance Inc. boosted its holdings in Balchem by 5.2% in the second quarter. Xponance Inc. now owns 2,046 shares of the basic materials company’s stock valued at $315,000 after acquiring an additional 102 shares during the last quarter. Institutional investors own 87.91% of the company’s stock.

Balchem Price Performance

Shares of BCPC opened at $179.69 on Thursday. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21. Balchem Co. has a 1 year low of $120.87 and a 1 year high of $186.03. The stock has a market cap of $5.84 billion, a P/E ratio of 49.01, a price-to-earnings-growth ratio of 5.46 and a beta of 0.65. The stock’s 50-day moving average price is $174.23 and its two-hundred day moving average price is $167.08.

Analyst Upgrades and Downgrades

BCPC has been the topic of several recent research reports. HC Wainwright raised their price target on Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a report on Monday, November 4th. StockNews.com upgraded Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.